Quang Vo, based in Seattle, Washington, United States, is currently a Principal Oncology MSL at Daiichi Sankyo, Inc., bringing experience from previous roles at Astrazeneca, Alexion Pharmaceuticals, Inc., National Institutes of Health and Celgene. Quang Vo holds a 2016 - 2017 Niaid, National Institute Of Health. With a robust skill set that includes Pharmacovigilance, Clinical Trials, Drug Safety, Clinical Pharmacology, Clinical Research and more, Quang Vo contributes valuable insights to the industry. Quang Vo has 2 emails and 1 mobile phone number on RocketReach.